Imricor Medical Systems, Inc. · ASX:IMR
Imricor Medical Systems — Shareholder Meeting (May 2026)
29 slides from Imricor Medical Systems's shareholder meeting presentation, May 2026
Slide 1: Annual General Meeting May 2026
rsonal use only Annual General Meeting May 2026 IMRICOR MEDICAL SYSTEMS, INC (ASX:IMR) WWW.IMRICOR.COM
Slide 2: Disclaimer
Disclaimer The material contained in this presentation is intended to be general background those which we expect, depending on the outcome of various factors. Investors and others information on Imricor Medical Systems, Inc. (Imricor) and its activities. are cautioned not to place undue reliance on
Slide 3: Please submit questions at any time throughout the meeting
Please submit questions at any time throughout the meeting To ask a question select the ‘Q&A’ icon rsonal use only Select the topic your question relates to. Type your question into the chat box at the bottom of the screen and press ‘Send’ Your question will be sent immediately for review 2026 AGM |
Slide 4: Voting online at the virtual meeting
Voting online at the virtual meeting When the Chair declares the poll open, select the ‘Vote’ icon and the rsonal use only voting options will appear on your screen To vote, select your voting direction. A tick will appear to confirm receipt of your vote To change your vote, select ‘Click here to ch
Slide 5: Imricor's Board of Directors and CFO
Imricor’s Board of Directors and CFO rsonal use only STEVE WEDAN MARK TIBBLES PETER MCGREGOR ANITA MESSAL President and Chief Executive Deputy Chair and Lead Non-executive Director Non-executive Director Officer, and Board Chair Independent Director JEFFREY LEIGHTON ALDO DENTI JONATHON GUT Non-execu
Slide 6: Chair's Address
rsonal use only Chair’s Address
Slide 7: We are Interventional Magnetic Resonance
We are Interventional Magnetic Resonance rsonal use only 2026 AGM | 7
Slide 8: Business of the Meeting
rsonal use only Business of the Meeting
Slide 9: Questions
rsonal use only Questions
Slide 10: Election of Class I Director – Mr Mark Tibbles
Item 1 – Election of Class I Director – Mr Mark Tibbles rsonal use only To consider and, if thought fit, to pass the following resolution as a separate ordinary resolution: “That Mr Mark Tibbles being a Director whose appointment as a Director expires at the conclusion of the Annual Meeting of the C
Slide 11: Election of Class I Director – Mr Mark Tibbles: Votes
Item 1 – Election of Class I Director – Mr Mark Tibbles rsonal use only Proxy and direct votes received in respect of this resolution: For Withheld Non-Votes Uncast 127,124,785 4,210,597 - - 96.79% 3.21% 2026 AGM | 11
Slide 12: Election of Class I Director – Mr Aldo Denti
Item 2 – Election of Class I Director – Mr Aldo Denti rsonal use only To consider and, if thought fit, to pass the following resolution as a separate ordinary resolution: “That Mr Aldo Denti being a Director whose appointment as a Director expires at the conclusion of the Annual Meeting of the Compa
Slide 13: Election of Class I Director – Mr Aldo Denti: Votes
Item 2 – Election of Class I Director – Mr Aldo Denti rsonal use only Proxy and direct votes received in respect of this resolution: For Withheld Non-Votes Uncast 131,282,559 52,823 - - 99.96% 0.04% 2026 AGM | 13
Slide 14: Approval of the 2019 Equity Incentive Plan and increase in reserved Shares
Item 3 – Approval of the 2019 Equity Incentive Plan and increase in reserved Shares rsonal use only To consider and, if thought fit, to pass the following resolution as a separate ordinary resolution: “That, for the purposes of section 19.2 of the Plan (defined below), Exception 13 of ASX Listing Ru
Slide 15: 2019 Equity Incentive Plan increase: Votes
Item 3 – Approval of the 2019 Equity Incentive Plan and increase in reserved Shares rsonal use only Proxy and direct votes received in respect of this resolution: For Against Abstain Non-Votes Uncast 101,958,451 22,923,488 52,523 - 6,400,920 81.61% 18.35% 0.04% 2026 AGM | 15
Slide 16: Grant of Options to Mr Steve Wedan, Chief Executive Officer
Item 4 – Grant of Options to Mr Steve Wedan, Chief Executive Officer of the Company rsonal use only To consider and, if thought fit, to pass the following resolutions as separate ordinary resolutions: That, for the purposes of ASX Listing Rule 10.14 and for all other purposes, approval is given for
Slide 17: Grant of Options to Mr Steve Wedan: Votes
Item 4 – Grant of Options to Mr Steve Wedan, Chief Executive Officer of the Company rsonal use only Proxy and direct votes received in respect of this resolution: For Against Abstain Non-Votes Uncast 120,624,314 5,012,822 51,340 - 5,646,906 95.97% 3.99% 0.04% 2026 AGM | 17
Slide 18: Grant of Restricted Stock Award to Mr Peter McGregor
Item 5 – Grant of Restricted Stock Award to Mr Peter McGregor, Non-Executive Director of the Company rsonal use only To consider and, if thought fit, to pass the following resolution as a separate ordinary resolution: “That, for the purposes of ASX Listing Rule 10.14 and for all other purposes, appr
Slide 19: Restricted Stock Award to Mr Peter McGregor: Votes
Item 5 – Grant of Restricted Stock Award to Mr Peter McGregor, Non-Executive Director of the Company rsonal use only Proxy and direct votes received in respect of this resolution: For Against Abstain Non-Votes Uncast 119,416,095 6,091,441 180,940 - 5,646,906 95.01% 4.85% 0.14% 2026 AGM | 19
Slide 20: Grant of Restricted Stock Award to Ms Anita Messal
Item 6 – Grant of Restricted Stock Award to Ms Anita Messal, Non-Executive Director of the Company rsonal use only To consider and, if thought fit, to pass the following resolution as a separate ordinary resolution: “That, for the purposes of ASX Listing Rule 10.14 and for all other purposes, approv
Slide 21: Restricted Stock Award to Ms Anita Messal: Votes
Item 6 – Grant of Restricted Stock Award to Ms Anita Messal, Non-Executive Director of the Company rsonal use only Proxy and direct votes received in respect of this resolution: For Against Abstain Non-Votes Uncast 119,650,249 5,857,287 180,940 - 5,646,906 95.20% 4.66% 0.14% 2026 AGM | 21
Slide 22: Grant of Restricted Stock Award to Mr Mark Tibbles
Item 7 – Grant of Restricted Stock Award to Mr Mark Tibbles, Non-Executive Director of the Company rsonal use only To consider and, if thought fit, to pass the following resolution as a separate ordinary resolution: “That, subject to Item 1 being approved, for the purposes of ASX Listing Rule 10.14
Slide 23: Restricted Stock Award to Mr Mark Tibbles: Votes
Item 7 – Grant of Restricted Stock Award to Mr Mark Tibbles, Non-Executive Director of the Company rsonal use only Proxy and direct votes received in respect of this resolution: For Against Abstain Non-Votes Uncast 119,654,249 5,853,287 180,940 - 5,646,906 95.20% 4.66% 0.14% 2026 AGM | 23
Slide 24: Grant of Restricted Stock Award to Mr Aldo Denti
Item 8 – Grant of Restricted Stock Award to Mr Aldo Denti, Non-Executive Director of the Company rsonal use only To consider and, if thought fit, to pass the following resolution as a separate ordinary resolution: “That, subject to Item 2 being approved, for the purposes of ASX Listing Rule 10.14 an
Slide 25: Restricted Stock Award to Mr Aldo Denti: Votes
Item 8 – Grant of Restricted Stock Award to Mr Aldo Denti, Non-Executive Director of the Company rsonal use only Proxy and direct votes received in respect of this resolution: For Against Abstain Non-Votes Uncast 120,159,057 5,348,479 180,940 - 5,646,906 95.60% 4.26% 0.14% 2026 AGM | 25
Slide 26: Ratification of the appointment of BDO USA, P.C.
Item 9 – Ratification of the appointment of BDO USA, P.C. as independent registered public accounting firm rsonal use only To consider and, if thought fit, to pass the following resolution as a separate ordinary resolution: “That the stockholders ratify and approve the appointment of BDO USA, P.C. a
Slide 27: Ratification of BDO USA, P.C.: Votes
Item 9 – Ratification of the appointment of BDO USA, P.C. as independent registered public accounting firm rsonal use only Proxy and direct votes received in respect of this resolution: For Against Abstain Non-Votes Uncast 131,197,135 137,424 823 - - 99.90% 0.10% 0.00% 2026 AGM | 27
Slide 28: Close of Meeting
rsonal use only Close of Meeting
Slide 29: Contact Information
Contact Information rsonal use only Investors & Australian Media: Simon Hinsley NWR Communications simon@nwrcommunications.com.au +61 401 809 653 Investors: Steve Wedan Executive Chair, President & CEO steve.wedan@imricor.com Nick Corkill Vice President, Corporate Strategy Nick.corkill@imricor.com +
Imricor Medical Systems — Shareholder Meeting (May 2026) on 6ix